CARDIOMETABOLIC INNOVATIONS: APPLICATIONS IN VASCULAR HEALTH

Sunday, November 2, 2025

9:00am - 10:00am PT

Moderator(s)

Joshua Beckman, MD

Chief, Division of Vascular Medicine
UT Southwestern Medical Center
Vascular Medicine
Dallas, Texas, United States

Disclosure(s): Janacare: Stockholder - Privately-held company
Medtronic: Consultant
Merck: Consultant
Novartis: Consultant
Novo Nordisk: Consultant
Regeneron: Consultant
tourmaline: Consultant
Ali Moran Baird, DNP, AGACNP

Director of Cardiac and Vascular Service Line
HCA Healthcare
Vascular Medicine
Nashville, Tennessee, United States

Disclosure(s): No financial relationships to disclose

Panel(s)

Kristen Alix, NP

Vascular Nurse Practitioner
University of Colorado Denver
Vascular Surgery
Aurora, Colorado, United States

Disclosure(s): No financial relationships to disclose
Marc Bonaca, MD, MPH

Professor
University of Colorado
Vascular Medicine
Aurora, Colorado, United States

Disclosure(s): 35Pharma, Inc.; Abbott Labratories; Agios Pharmaceuticals, Inc.; Alexion Pharmaceuticals; Amgen; Anthos Therapeutics, Inc.; Arrowhead Pharmaceuticals; Autonomy Bio, Inc.; Bayer; Bristol-Myers Squibb; Cleerly, Inc.; Cook Regentec: Grants/Research Support Recipient
Eidos Therapeutics, Inc.; EluraBio, Inc.; Esperion Therapeutics, Inc.; Faraday Pharmaceuticals, Inc.; Gasherbrum Bio, Inc.; Insmed; IsomAb Limited; JanOne Biotech Holdings, Inc.; Janssen Pharmaceuticals, Inc.; Lexicon Pharmaceuticals, Inc.: Grants/Research Support Recipient
Lilly USA; Medison Pharma; Merck Sharp & Dohme Corp.; Nectero Medical, Inc.; NewAmsterdam Pharma; Novartis Pharmaceuticals; Novo Nordisk, Inc.; Pfizer; Piper Sandler & Co; PPD Development; Prothena Biosciences; Sanofi; Silence Therapeutics: Grants/Research Support Recipient
Stealth BioTherapeutic, Inc.; Regeneron; Tourmaline Bio, Inc.; VarmX; Verve Therapeutics: Grants/Research Support Recipient
Teresa Carman, MD, RPVI, MSVM

Director, Vascular Medicine
University Hospitals Cleveland Medical Center
Vascular Medicine
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Rachel Edwards, MS

Nurse Practitioner
Ohio Health
Interventional Cardiology
West Jefferson, Ohio, United States

Disclosure(s): No financial relationships to disclose
Christy Willocks, NP-BC

Nurse Practitioner
Ballad CVA Heart Institute
Vascular Medicine
Kingsport, Tennessee, United States

Disclosure(s): No financial relationships to disclose

Presentations:

9:00am - 9:07am PT

Overview of Cardiometabolic Syndrome and Clinics
Speaker: Rachel Edwards, MS – Ohio Health
9:07am - 9:14am PT

How Do Cardiometabolic Medications Apply to the Vascular Patient Population?
Speaker: Marc P. Bonaca, MD, MPH – University of Colorado
9:14am - 9:21am PT

Hyperlipidemia
Speaker: Ali Moran Baird, DNP, AGACNP – HCA Healthcare
9:21am - 9:30am PT

Panel Discussion
9:30am - 9:37am PT

New Options for Antithrombotic Therapy
Speaker: Teresa L. Carman, MD, RPVI, MSVM – University Hospitals Cleveland Medical Center
9:37am - 9:44am PT

New Hypertension Guidelines and Hypertension Clinics
Speaker: Kristen Alix, NP – University of Colorado Denver
9:44am - 9:51am PT

When to Refer for Renal Denervation
Speaker: Christy Willocks, NP-BC – Ballad CVA Heart Institute
9:51am - 10:00am PT

Panel Discussion